Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People's Republic of China

被引：4

作者：

Mao, Ningying ^{[1
]}

Lesher, Beth

Liu, Qifa ^{[3
]}

Qin, Lei ^{[2
]}

Chen, Yixi ^{[4
]}

Gao, Xin ^{[2
]}

Earnshaw, Stephanie R. ^{[5
]}

McDade, Cheryl L. ^{[5
]}

Charbonneau, Claudie ^{[6
]}

机构：

[1] China Pharmaceut Univ, Sch Int Pharmaceut Business, Nanjing, Jiangsu, Peoples R China

[2] Pharmerit Int, 4350 East West Highway,Suite 430, Bethesda, MD 20814 USA

[3] Southern Med Univ, Nanfang Hosp, Hematol Dept, Guangzhou, Guangdong, Peoples R China

[4] Pfizer Investment Co Ltd, Beijing, Peoples R China

[5] RTI Hlth Solut, Res Triangle Pk, NC USA

[6] Pfizer Int Operat, Paris, France

来源：

CLINICOECONOMICS AND OUTCOMES RESEARCH | 2016年 / 8卷

关键词：

aspergillosis; cost-effectiveness analysis; voriconazole; caspofungin; itraconazole;

D O I：

10.2147/CEOR.S101015

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Invasive fungal infections (IFIs) require rapid diagnosis and treatment. A decision-analytic model was used to estimate total costs and survival associated with a diagnostic-driven (DD) or an empiric treatment approach in neutropenic patients with hematological malignancies receiving chemotherapy or autologous/allogeneic stem cell transplants in Shanghai, Beijing, Chengdu, and Guangzhou, the People's Republic of China. Treatment initiation for the empiric approach occurred after clinical suspicion of an IFI; treatment initiation for the DD approach occurred after clinical suspicion and a positive IFI diagnostic test result. Model inputs were obtained from the literature; treatment patterns and resource use were based on clinical opinion. Total costs were lower for the DD versus the empiric approach in Shanghai ((sic)3,232 vs (sic)4,331), Beijing ((sic)3,894 vs (sic)4,864), Chengdu, ((sic)4,632 vs (sic)5,795), and Guangzhou ((sic)8,489 vs (sic)9,795). Antifungal administration was lower using the DD (5.7%) than empiric (9.8%) approach, with similar survival rates. Results from one-way and probabilistic sensitivity analyses were most sensitive to changes in diagnostic test sensitivity and IFI incidence; the DD approach dominated the empiric approach in 88% of scenarios. These results suggest that a DD compared to an empiric treatment approach in the People's Republic of China may be cost saving, with similar overall survival in immunocompromised patients with suspected IFIs.

引用

页码：275 / 285

页数：11